Lipum AB (LIPUM) - Cash Flow Conversion Efficiency

Latest as of December 2025: 1.465x

Based on the latest financial reports, Lipum AB (LIPUM) has a cash flow conversion efficiency ratio of 1.465x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-6.95 Million ≈ $-747.82K USD) by net assets (Skr-4.74 Million ≈ $-510.31K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Lipum AB - Cash Flow Conversion Efficiency Trend (2018–2025)

This chart illustrates how Lipum AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Lipum AB balance sheet liabilities for a breakdown of total debt and financial obligations.

Lipum AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Lipum AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
FreeMs Corporation KQ:053160	0.004x
Wemade Max Co. Ltd KQ:101730	-0.016x
Radiant Globaltech Bhd KLSE:0202	0.050x
Ma Kuang Healthcare Holding Ltd TWO:4139	0.097x
DLP Resources Inc V:DLP	-0.296x
Microba Life Sciences Ltd AU:MAP	-0.287x
Korea SPAC 2 KQ:206400	-0.010x
Globus Maritime Ltd NASDAQ:GLBS	0.020x

Annual Cash Flow Conversion Efficiency for Lipum AB (2018–2025)

The table below shows the annual cash flow conversion efficiency of Lipum AB from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see Lipum AB (LIPUM) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr-4.74 Million ≈ $-510.31K	Skr-34.94 Million ≈ $-3.76 Million	7.368x	+287.28%
2024-12-31	Skr22.00 Million ≈ $2.37 Million	Skr-86.53 Million ≈ $-9.31 Million	-3.934x	+50.21%
2023-12-31	Skr4.57 Million ≈ $492.02K	Skr-36.13 Million ≈ $-3.89 Million	-7.902x	-322.88%
2022-12-31	Skr28.05 Million ≈ $3.02 Million	Skr-52.41 Million ≈ $-5.64 Million	-1.869x	-51.90%
2021-12-31	Skr27.88 Million ≈ $3.00 Million	Skr-34.30 Million ≈ $-3.69 Million	-1.230x	+79.51%
2020-12-31	Skr3.23 Million ≈ $347.31K	Skr-19.37 Million ≈ $-2.08 Million	-6.002x	-391.71%
2019-12-31	Skr15.87 Million ≈ $1.71 Million	Skr-19.37 Million ≈ $-2.08 Million	-1.221x	+98.83%
2018-12-31	Skr185.26K ≈ $19.94K	Skr-19.37 Million ≈ $-2.08 Million	-104.555x	--

About Lipum AB

ST:LIPUM Sweden Biotechnology

Market Cap

$32.76 Million

Skr304.40 Million SEK

Market Cap Rank

#23424 Global

#452 in Sweden

Share Price

Skr14.35

Change (1 day)

+0.70%

52-Week Range

Skr9.10 - Skr16.00

All Time High

Skr26.40